ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,916.98
      0.40%
      US Tech 100
      20,190.40
      0.95%
      Dow Jones
      43,268.94
      -0.28%
      Brent Oil
      73.085
      0.00%
      Bitcoin
      92,359.87
      0.02%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Prime Medicine Inc (PRME) Quote

      Prime Medicine Inc

      Prime Medicine Inc (PRME)

      Prim SA
      Prim SA
      Prim SA
      Prim SA
      Prime Drink Group Corp
      3.17
      -0.01
      (-0.31%)
      At close: November 19 4:00PM
      Delayed by 15 minutes
      3.17
      0.005
      ( 0.16% )
      After Hours: 7:26PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      3.17
      Bid
      3.17
      Ask
      3.49
      Volume
      986,909
      3.063 Day's Range 3.24
      3.145 52 Week Range 9.86
      Market Cap
      380.498M
      Previous Close
      3.18
      Open
      3.19
      Last Trade
      20
      @
      3.32
      Last Trade Time
      19:26:55
      Financial Volume
      $ 3,097,291
      VWAP
      3.1384
      Average Volume (3m)
      1,538,147
      Shares Outstanding
      120,030,813
      Dividend Yield
      -
      PE Ratio
      -1.91
      Earnings Per Share (EPS)
      -1.65
      Revenue
      -
      Net Profit
      -198.13M

      About Prime Medicine Inc

      Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome a... Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.primemedicine.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Prime Medicine Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PRME. The last closing price for Prime Medicine was $3.18. Over the last year, Prime Medicine shares have traded in a share price range of $ 3.145 to $ 9.86.

      Prime Medicine currently has 120,030,813 shares outstanding. The market capitalization of Prime Medicine is $381.70 million. Prime Medicine has a price to earnings ratio (PE ratio) of -1.91.

      Ask ADVFN Intelligence (AI)

      PRME Latest News

      More News

      FeaturedKey Metals Surge, Unlocking New Opportunities for Savvy Mining Investors

      11 hours ago

      FeaturedGreenlane Signs New U.S. Distribution Agreement with Veriteque USA, Manufacturer of the SwabTek™ and Verifique™ Brand of Field Test Kits

      11 hours ago

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 12 2024
      Edgar (US Regulatory)

      Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates

      -- Presented initial in vivo data for universal liver-targeted LNP and Wilson’s Disease program at ESGCT; initiated IND-enabling activities for Wilson’s Disease program in 4Q 2024 and remains on...

      November 12 2024
      GlobeNewswire Inc.

      Prime Medicine to Participate in Upcoming Investor Conferences

      CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...

      November 06 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      October 24 2024
      Edgar (US Regulatory)

      Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

      Delivery of Prime Editors with a proprietary, universal liver-targeted LNP was well tolerated, with no safety concerns or detectable off-target edits observed across multiple preclinical studies...

      October 24 2024
      GlobeNewswire Inc.

      Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings

      -- On-track to initiate IND-enabling activities for Wilson’s Disease program in 4Q 2024, with IND or CTA filing expected in 1H 2026 -- CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Prime...

      October 15 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      September 30 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.168-26.92485016144.3384.493.14514628073.60743014CS
      4-1.19-27.29357798174.364.713.14510339253.96282313CS
      12-1.29-28.92376681614.465.023.14515381473.84438175CS
      26-4.02-55.91098748267.198.273.14511599284.63972983CS
      52-3.48-52.33082706776.659.863.1459176245.50548691CS
      156-15.8-83.289404322618.9721.73013.1456174847.72227955CS
      260-15.8-83.289404322618.9721.73013.1456174847.72227955CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.245
      (50.58%)
      		60.09M
      HOTHHoth Therapeutics Inc
      $ 1.12
      (36.92%)
      		11.37M
      DBGIDigital Brands Group Inc
      $ 0.151
      (29.50%)
      		47.95M
      KITTNauticus Robotics Inc
      $ 1.15
      (26.35%)
      		272.83k
      JXJTJX Luxventure Ltd
      $ 1.64
      (26.15%)
      		729
      PRFXPainReform Ltd
      $ 1.0701
      (-23.56%)
      		2.29M
      POWLPowell Industries Inc
      $ 265.00
      (-15.17%)
      		202.77k
      WKHSWorkhorse Group Inc
      $ 1.05
      (-13.93%)
      		2.24M
      STISolidion Technology Inc
      $ 0.5602
      (-11.79%)
      		542.51k
      HWHHWH International Inc
      $ 0.6565
      (-9.56%)
      		1.37k
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.245
      (50.58%)
      		60.1M
      DBGIDigital Brands Group Inc
      $ 0.1525
      (30.79%)
      		47.95M
      HOTHHoth Therapeutics Inc
      $ 1.1203
      (36.96%)
      		11.37M
      ELABElevai Labs Inc
      $ 0.0218
      (2.35%)
      		10.91M
      SMXSMX Security Matters Public Company
      $ 0.2769
      (13.95%)
      		6.25M

      PRME Discussion

      View Posts
      Monksdream Monksdream 1 month ago
      PRME under $5
      👍️0
      Monksdream Monksdream 2 months ago
      PRME new 52 week low
      👍️0
      Invest-in-America Invest-in-America 2 months ago
      PRME: Glad I grabbed a chunk of THIS ONE!!!!
      👍️0
      PonkenPlonken PonkenPlonken 2 months ago
      "Under the terms of the agreement, Prime Medicine will receive a $55 million upfront payment and a $55 million equity investment from Bristol Myers Squibb. Prime Medicine is also eligible to receive more than $3.5 billion in milestones,..."

      "On the Effective Date, the Company entered into the Purchase Agreement with BMS, pursuant to which the Company agreed to issue and sell, and BMS agreed to purchase, in an unregistered offering (the “Offering”), 11,006,163 shares [...] for an aggregate purchase price of $55.0 million..."
      👍️0
      Monksdream Monksdream 2 months ago
      PRME new 52=week low
      👍️0
      wiwineguy wiwineguy 3 months ago
      K. I'm in!
      👍️0
      Monksdream Monksdream 3 months ago
      DAKT
      👍️0
      wiwineguy wiwineguy 3 months ago
      You are amazing Monk. Any recommendations
      👍️0
      Monksdream Monksdream 3 months ago
      PRME under $5
      👍️0
      Monksdream Monksdream 3 months ago
      PRME new 52 week low
      👍️0
      Monksdream Monksdream 4 months ago
      PRME under $6
      👍️0
      Monksdream Monksdream 5 months ago
      PRME under $10:
      👍️0
      Monksdream Monksdream 6 months ago
      Great post
      Friday Cathie Wood bought more shares for her flagship Ark Fund (ARKK)
      I think she has been buying on the decline
      She isn’t particularly interested in how well or how lousy the management controls costs it’s the potential she believes exists
      There are about a dozen, if not more, listed gene editing companies
      Not all will make it before they run out of money and have to raise more operating capital
      Notice the $2 to $4 bounces on the way to lower lows
      👍️0
      Monksdream Monksdream 6 months ago
      PRME under $10
      👍️0
      jondoeuk jondoeuk 6 months ago
      PRME vs Tome vs Tessera vs NTLA vs CRSP vs...!

      They fact this article needs to be written could mean a legal battle is coming https://www.nature.com/articles/s41587-024-02208-0
      👍️0
      NY1972 NY1972 7 months ago
      This $500M company burns $200M a year. These PhDs have been spoiled by Wall St. when money was cheap. Who wants to be their sugar daddy?
      👍️0
      jondoeuk jondoeuk 7 months ago
      I'm sure in the (near) future they will (functionally) cure (rare) diseases, but not before they dilute a whole bunch more.
      👍️0
      jondoeuk jondoeuk 9 months ago
      The CEO has been contently telling investors how easy it would be to bring in funding through partnerships and how difficult capital markets are. Yet they did a secondary. He needs to go. Also, I don't think their IP is gatekeeping others.
      👍️0

      Your Recent History

      NASDAQ
      PRME
      Prime Medicine
      BOV
      AURA33
      Aura Minerals
      Delayed Upgrade Clock